A federal agency may soon approve the use of MDMA, also known as ecstasy, to help treat post-traumatic stress disorder (PTSD).Â
Advocates and lawmakers across the political spectrum are optimistic about its chances for approval and pushing for a speedy rollout of so-called “MDMA-assisted therapy,†which they say could finally reduce the more than 6,000 veterans who die by suicide each year.
READ MORE: https://trib.al/Oz6jXZY
Correction: Lykos, whose primary shareholder is the Multidisciplinary Association for Psychedelic Studies, conducted the Phase 3 trial.
** (Disclaimer: This video content is intended for educational and informational purposes only) **
